Eric G. Schmuck

Eric G. Schmuck

Auto-generated profile, based on publicly available information

Eric G. Schmuck

University of Wisconsin School of Medicine and Public Health

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
JKJohn A. Kink
John A. Kink
MFMatthew H. Forsberg
Matthew H. Forsberg
SRSofiya Reshetylo
Sofiya Reshetylo
SBSoroush Besharat
Soroush Besharat
CCCharlie J. Childs
Charlie J. Childs
CCChristian M. Capitini
Christian M. Capitini
In the setting of radiation-induced trauma, exposure to high levels of radiation can cause an acute radiation syndrome (ARS) causing bone marrow (BM) failure, leading to life-threatening infections, anemia, and thrombocytopenia. We have previously shown that human macrophages educated with human mesenchymal stem cells (MSCs) by coculture can significantly enhance survival of mice exposed to lethal irradiation. In this study, we investigated whether exosomes isolated from MSCs could replace direct coculture with MSCs to generate exosome educated macrophages (EEMs). Functionally unique phenotypes were observed by educating macrophages with exosomes from MSCs (EEMs) primed with bacterial lipopolysaccharide (LPS) at different concentrations (LPS-low EEMs or LPS-high EEMs). LPS-high EEMs were significantly more effective than uneducated macrophages, MSCs, EEMs, or LPS-low EEMs in extending survival after lethal ARS in vivo. Moreover, LPS-high EEMs significantly reduced clinical signs of radiation injury and restored hematopoietic tissue in the BM and spleen as determined by complete blood counts and histology. LPS-high EEMs showed significant increases in gene expression of STAT3, secretion of cytokines like IL-10 and IL-15, and production of growth factors like FLT-3L. LPS-EEMs also showed increased phagocytic activity, which may aid with tissue remodeling. LPS-high EEMs have the potential to be an effective cellular therapy for the management of ARS.

1 December 2020 in Journal of Immunology and Regenerative Medicine
Verified
Journal Article
Closed access
SRSushmita Roy
Sushmita Roy
KSKeith Spinali
Keith Spinali
ESEric G. Schmuck
Eric G. Schmuck
JKJohn A. Kink
John A. Kink
PHPeiman Hematti
Peiman Hematti
ARAmish N. Raval
Amish N. Raval

17 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ARAmish N. Raval
Amish N. Raval
ESEric G. Schmuck
Eric G. Schmuck
VLVladislav Leonov
Vladislav Leonov
SRSushmita Roy
Sushmita Roy
YSYukihiro Saito
Yukihiro Saito
TKTimothy Kamp
Timothy Kamp
Background The adult human heart following a large myocardial infarction is unable to regenerate heart muscle and instead forms scar with the risk of progressive heart failure. Large animal studies have shown that intramyocardial injection of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) following a myocardial infarction result in cell grafts but also ventricular arrhythmias. We hypothesized that intramyocardial injection of committed cardiac progenitor cells (CCPs) derived from iPSCs, combined with cardiac fibroblast-derived extracellular matrix (cECM) to enhance cell retention will: i) form cardiomyocyte containing functional grafts, ii) be free of ventricular arrhythmias and iii) restore left ventricular contractility in a post-myocardial infarction (MI) cardiomyopathy swine model. Methods hiPSCs were differentiated using bioreactors and small molecules to produce a population of committed cardiac progenitor cells (CCPs). MI was created using a coronary artery balloon occlusion and reperfusion model in Yucatan mini pigs. Four weeks later, epicardial needle injections of CCPs+cECM were performed in a small initial feasibility cohort, and then transendocardial injections (TEI) of CCPs+cECM, CCPs alone, cECM alone or vehicle control into the peri-infarct region in a larger randomized cohort. A 4-drug immunosuppression regimen was administered to prevent rejection of human CCPs. Arrhythmias were evaluated using implanted event recorders. Magnetic resonance imaging (MRI) and invasive pressure volume assessment were used to evaluate left ventricular anatomic and functional performance, including viability. Detailed histology was performed on the heart to detect human grafts. Results A scalable biomanufacturing protocol was developed generating CCPs which can efficiently differentiate to cardiomyocytes or endothelial cells in vitro. Intramyocardial delivery of CCPs to post-MI porcine hearts resulted in engraftment and differentiation of CCPs to form ventricular cardiomyocyte rich grafts. There was no significant difference in cardiac MRI-based measured cardiac volumes or function between control, CCP and CCP+cECM groups; however, dobutamine stimulated functional reserve was improved in CCP and CCP+cECM groups. TEI delivery of CCPs with or without cECM did not result in tumors or trigger ventricular arrhythmias. Conclusions CCPs are a promising cell source for post-MI heart repair using clinically relevant TEI with a low risk of engraftment ventricular arrhythmias.


1 November 2018 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Open access
JZJinhua Zhang
Jinhua Zhang
RTRan TAO
Ran TAO
KCKatherine Campbell
Katherine Campbell
JCJuliana Carvalho
Juliana Carvalho
EREdward Ruiz
Edward Ruiz
TKTimothy Kamp
Timothy Kamp

4 April 2024 in Biomedical Materials & Devices
Verified
Journal Article
Closed access
PDF file
PEParker J. Esswein
Parker J. Esswein
MFMacy C. Frank
Macy C. Frank
VOVanessa J. Obrycki
Vanessa J. Obrycki
LKLars S. Krugel
Lars S. Krugel
GZGabrielle N. Zuern
Gabrielle N. Zuern
ARAmish N. Raval
Amish N. Raval